|
|
Volumn 2, Issue 2, 2002, Pages 109-118
|
|
Recombinant adenovirus-mediated cytotoxic gene therapy and lymphoproliferative disorders: analysis based on pharmacodynamics.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ALPHAVBETA5 INTEGRIN;
CAR RECEPTOR;
INTEGRIN;
MEMBRANE PROTEIN;
VIRUS RECEPTOR;
VITRONECTIN RECEPTOR;
ANIMAL;
FLOW CYTOMETRY;
GENE TARGETING;
GENE THERAPY;
GENE VECTOR;
GENETICS;
HISTIOCYTIC LYMPHOMA;
HUMAN;
HUMAN ADENOVIRUS;
LYMPHOPROLIFERATIVE DISEASE;
METABOLISM;
METHODOLOGY;
PATHOLOGY;
REVIEW;
VIRION;
ADENOVIRUSES, HUMAN;
ANIMALS;
FLOW CYTOMETRY;
GENE TARGETING;
GENE THERAPY;
GENETIC VECTORS;
HUMANS;
INTEGRIN ALPHAVBETA3;
INTEGRINS;
LYMPHOMA, LARGE-CELL;
LYMPHOPROLIFERATIVE DISORDERS;
MEMBRANE PROTEINS;
RECEPTORS, VIRUS;
RECEPTORS, VITRONECTIN;
VIRION;
|
|
EID: 0036637561
PISSN: 15680088
EISSN: None
Source Type: Journal
DOI: 10.2174/1568008023340703 Document Type: Review |
|
Times cited : (4)
|
|
References (57)
|
